• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血红蛋白是低氧血症合并肺动静脉畸形患者动脉血氧含量的重要决定因素。

Hemoglobin Is a Vital Determinant of Arterial Oxygen Content in Hypoxemic Patients with Pulmonary Arteriovenous Malformations.

机构信息

1 School of Medicine, Imperial College London.

2 Respiratory Medicine, Imperial College Healthcare NHS Trust.

出版信息

Ann Am Thorac Soc. 2017 Jun;14(6):903-911. doi: 10.1513/AnnalsATS.201611-872OC.

DOI:10.1513/AnnalsATS.201611-872OC
PMID:28267932
Abstract

RATIONALE

Pa and Sa are commonly measured in respiratory practice, but arterial oxygen content (Ca) refers to the volume of oxygen delivered to the tissues per unit blood volume. Ca is calculated from Sa and the hemoglobin concentration in blood, recognizing that each gram of hemoglobin can transport approximately 1.34 ml of oxygen when fully saturated.

OBJECTIVES

To prospectively evaluate serial changes in Ca in humans, incorporating and excluding dynamic changes to oxygenation and hemoglobin parameters that may occur during life.

METHODS

A cohort of 497 consecutive patients at risk of both hypoxemia and anemia were recruited. The patients had radiologically proven pulmonary arteriovenous malformations (PAVMs), which result in hypoxemia due to right-to-left shunting, and concurrent hereditary hemorrhagic telangiectasia, which placed them at risk of iron deficiency anemia due to recurrent hemorrhagic iron losses. Presentation Sa (breathing room air, by pulse oximetry), hemoglobin, red cell and iron indices were measured, and Ca calculated as Sa × hemoglobin × 1.34 ml/g. Serial measurements were evaluated in 100 cases spanning up to 32.1 (median, 10.5) years.

RESULTS

Presentation Ca ranged from 7.6 to 27.5 (median, 17.6) ml/dl. Ca did not change appreciably across the Sa quartiles. In contrast, hemoglobin ranged from 5.9 to 21.8 g/dl (median, 14.1 g/dl), with a linear increase in Ca across hemoglobin quartiles. After PAVM embolization and an immediate increase in Sa, hemoglobin fell and Ca was unchanged 1.6-12 (median, 4) months later. When hemoglobin fell because of iron deficiency, there was no change in Sa. Similarly, when hemoglobin rose after iron treatment, there was no change in Sa, and the expected Ca increment was observed. These relationships were not evident during pregnancy when hemoglobin fell, and PAVMs usually deteriorated: in pregnancy Sa commonly increased, and serial Ca values (incorporating hemodilution/anemia) more accurately reflected deteriorating PAVM status. An apparent fall in Ca with age in females was attributable to the development of iron deficiency. There was an unexplained increase in Ca with age in follow-up of males after embolization.

CONCLUSIONS

Hemoglobin/Ca should be further incorporated into oxygenation considerations. More attention should be given to modest changes in hemoglobin that substantially modify Ca.

摘要

理由

Pa 和 Sa 常用于呼吸实践中,但动脉血氧含量 (Ca) 是指单位血容量输送给组织的氧量。Ca 是根据 Sa 和血液中的血红蛋白浓度计算出来的,因为当血红蛋白完全饱和时,每克血红蛋白可以运输大约 1.34 毫升的氧气。

目的

前瞻性评估人类 Ca 的连续变化,纳入并排除生命过程中可能发生的氧合和血红蛋白参数的动态变化。

方法

招募了一组有发生低氧血症和贫血风险的 497 例连续患者。这些患者患有放射学证实的肺动静脉畸形 (PAVM),由于右向左分流导致低氧血症,同时患有遗传性出血性毛细血管扩张症,由于反复出血性铁丢失,他们有缺铁性贫血的风险。测量了患者的 Sa(在呼吸室内空气时,通过脉搏血氧仪测量)、血红蛋白、红细胞和铁指数,并计算 Ca 为 Sa×血红蛋白×1.34 ml/g。对 100 例跨度长达 32.1 年(中位数 10.5 年)的连续测量值进行了评估。

结果

患者的初始 Ca 范围为 7.6 至 27.5(中位数 17.6)ml/dl。Sa 的四分位数之间 Ca 没有明显变化。相比之下,血红蛋白范围为 5.9 至 21.8 g/dl(中位数 14.1 g/dl),随着血红蛋白四分位数的增加,Ca 呈线性增加。在 PAVM 栓塞和 Sa 立即增加后,血红蛋白下降,而 1.6-12 个月后 Ca 保持不变(中位数为 4 个月)。当血红蛋白因缺铁而下降时,Sa 没有变化。同样,当铁治疗后血红蛋白升高时,Sa 没有变化,并且观察到预期的 Ca 增加。这些关系在怀孕期间血红蛋白下降时并不明显,而 PAVM 通常会恶化:怀孕期间 Sa 通常增加,而连续的 Ca 值(包括血液稀释/贫血)更准确地反映了 PAVM 状态的恶化。女性中 Ca 随年龄的增长而下降归因于缺铁的发展。在栓塞后男性的随访中,Ca 随年龄的增长而增加,原因不明。

结论

应进一步将血红蛋白/Ca 纳入氧合考虑因素。应更加关注血红蛋白的适度变化,因为这会显著改变 Ca。

相似文献

1
Hemoglobin Is a Vital Determinant of Arterial Oxygen Content in Hypoxemic Patients with Pulmonary Arteriovenous Malformations.血红蛋白是低氧血症合并肺动静脉畸形患者动脉血氧含量的重要决定因素。
Ann Am Thorac Soc. 2017 Jun;14(6):903-911. doi: 10.1513/AnnalsATS.201611-872OC.
2
Arterial oxygen content is precisely maintained by graded erythrocytotic responses in settings of high/normal serum iron levels, and predicts exercise capacity: an observational study of hypoxaemic patients with pulmonary arteriovenous malformations.在血清铁水平高/正常的情况下,动脉血氧含量通过分级红细胞增多反应精确维持,并可预测运动能力:一项对低氧血症性肺动静脉畸形患者的观察性研究。
PLoS One. 2014 Mar 17;9(3):e90777. doi: 10.1371/journal.pone.0090777. eCollection 2014.
3
Pulmonary arteriovenous malformations.肺动静脉畸形
Am J Respir Crit Care Med. 2014 Dec 1;190(11):1217-28. doi: 10.1164/rccm.201407-1254CI.
4
Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia.肺动静脉畸形:遗传性出血性毛细血管扩张症患者的筛查程序及肺血管造影
Chest. 1999 Aug;116(2):432-9. doi: 10.1378/chest.116.2.432.
5
Veterans Specific Activity Questionnaire (VSAQ): a new and efficient method of assessing exercise capacity in patients with pulmonary arteriovenous malformations.退伍军人特定活动问卷 (VSAQ):一种评估肺动静脉畸形患者运动能力的新方法。
BMJ Open Respir Res. 2019 Mar 1;6(1):e000351. doi: 10.1136/bmjresp-2018-000351. eCollection 2019.
6
Effect of percutaneous transcatheter embolization on pulmonary function, right-to-left shunt, and arterial oxygenation in patients with pulmonary arteriovenous malformations.经皮经导管栓塞术对肺动静脉畸形患者肺功能、右向左分流及动脉氧合的影响。
Am Rev Respir Dis. 1990 Aug;142(2):420-5. doi: 10.1164/ajrccm/142.2.420.
7
Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients.肺动静脉畸形:53例患者经弹簧圈栓塞治疗的结果
AJR Am J Roentgenol. 1995 Nov;165(5):1119-25. doi: 10.2214/ajr.165.5.7572487.
8
Cerebral Abscess Associated With Odontogenic Bacteremias, Hypoxemia, and Iron Loading in Immunocompetent Patients With Right-to-Left Shunting Through Pulmonary Arteriovenous Malformations.免疫功能正常患者右向左分流通过肺动静脉畸形并发牙源性菌血症、低氧血症和铁过载相关脑脓肿。
Clin Infect Dis. 2017 Aug 15;65(4):595-603. doi: 10.1093/cid/cix373.
9
Sensitivity and specificity of radioisotope right-left shunt measurements and pulse oximetry for the early detection of pulmonary arteriovenous malformations.
Chest. 1999 Jan;115(1):109-13. doi: 10.1378/chest.115.1.109.
10
Exercise capacity reflects airflow limitation rather than hypoxaemia in patients with pulmonary arteriovenous malformations.在患有肺动静脉畸形的患者中,运动能力反映了气流受限而不是低氧血症。
QJM. 2019 May 1;112(5):335-342. doi: 10.1093/qjmed/hcz023.

引用本文的文献

1
In Situ Monitoring of Morphology Changes and Oxygenation State of Human Erythrocytes During Surfactant-Induced Hemolysis.表面活性剂诱导溶血过程中人体红细胞形态变化及氧合状态的原位监测
Cells. 2025 Mar 21;14(7):469. doi: 10.3390/cells14070469.
2
Hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症
Nat Rev Dis Primers. 2025 Jan 9;11(1):1. doi: 10.1038/s41572-024-00585-z.
3
A Narrative Review of Impact of Incentive Spirometer Respiratory Training in Long COVID.关于激励式肺量计呼吸训练对长期新冠影响的叙述性综述
Int J Gen Med. 2024 Nov 13;17:5233-5246. doi: 10.2147/IJGM.S492772. eCollection 2024.
4
Evaluation of the hemoglobin cutoff point for anemia in adult women residents of different altitudinal levels in Peru.评估秘鲁不同海拔高度成年女性居民贫血的血红蛋白切点。
PLoS One. 2024 Jul 30;19(7):e0307502. doi: 10.1371/journal.pone.0307502. eCollection 2024.
5
Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT.导致提前终止密码子的突变可区分并产生 HHT 的细胞和临床变异性。
Blood. 2024 May 30;143(22):2314-2331. doi: 10.1182/blood.2023021777.
6
Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study.遗传性出血性毛细血管扩张症的产科和新生儿并发症:一项回顾性研究。
BJOG. 2023 Feb;130(3):303-311. doi: 10.1111/1471-0528.17303. Epub 2022 Oct 9.
7
Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的突变和表型特征。
Blood. 2020 Oct 22;136(17):1907-1918. doi: 10.1182/blood.2019004560.
8
Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature.遗传性出血性毛细血管扩张症与妊娠:文献复习。
Orphanet J Rare Dis. 2020 Jan 7;15(1):5. doi: 10.1186/s13023-019-1286-z.
9
Veterans Specific Activity Questionnaire (VSAQ): a new and efficient method of assessing exercise capacity in patients with pulmonary arteriovenous malformations.退伍军人特定活动问卷 (VSAQ):一种评估肺动静脉畸形患者运动能力的新方法。
BMJ Open Respir Res. 2019 Mar 1;6(1):e000351. doi: 10.1136/bmjresp-2018-000351. eCollection 2019.
10
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者使用沙利度胺和贝伐珠单抗的安全性。
Orphanet J Rare Dis. 2019 Feb 4;14(1):28. doi: 10.1186/s13023-018-0982-4.